135 related articles for article (PubMed ID: 36223033)
1. FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis.
Huang Y; Shan G; Yi Y; Liang J; Hu Z; Bi G; Chen Z; Xi J; Ge D; Wang Q; Tan L; Jiang W; Zhan C
Cell Oncol (Dordr); 2022 Dec; 45(6):1383-1399. PubMed ID: 36223033
[TBL] [Abstract][Full Text] [Related]
2. TPX2 influences the regulation of macrophage polarization via the NF-κB pathway in lung adenocarcinoma.
Wang L; Zhang H; Li Y; Li L
Life Sci; 2024 Mar; 340():122437. PubMed ID: 38266813
[TBL] [Abstract][Full Text] [Related]
3. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.
Dai X; Lu L; Deng S; Meng J; Wan C; Huang J; Sun Y; Hu Y; Wu B; Wu G; Lovell JF; Jin H; Yang K
Theranostics; 2020; 10(20):9332-9347. PubMed ID: 32802195
[No Abstract] [Full Text] [Related]
4. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
5. ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway.
Cao J; Zhang H; Wei X; Zhou H
Chem Biol Drug Des; 2024 Jan; 103(1):e14445. PubMed ID: 38230786
[TBL] [Abstract][Full Text] [Related]
6. LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.
Li Y; Chen C; Liu HL; Zhang ZF; Wang CL
Cell Mol Biol Lett; 2022 Oct; 27(1):91. PubMed ID: 36221069
[TBL] [Abstract][Full Text] [Related]
7. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.
Li H; Guo H; Huang Q; Wang S; Li X; Qiu M
Respir Res; 2023 Oct; 24(1):252. PubMed ID: 37880717
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma.
Yin JZ; Shi XQ; Wang MD; Du H; Zhao XW; Li B; Yang MH
Int Immunopharmacol; 2023 Apr; 117():109899. PubMed ID: 36827926
[TBL] [Abstract][Full Text] [Related]
10. STK11 mutation affects the killing effect of NK cells to promote the progression of lung adenocarcinoma.
Huang Y; Zhang H; Feng J; Tang B
APMIS; 2022 Nov; 130(11):647-656. PubMed ID: 35988018
[TBL] [Abstract][Full Text] [Related]
11. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
12. UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling.
Wu S; Xie L; Cheng S; Fan Z; Sang H; Li Q
Pathol Res Pract; 2022 Apr; 232():153762. PubMed ID: 35220170
[TBL] [Abstract][Full Text] [Related]
13. A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages.
Bai Y; Zhang X; Zhou J; Guo J; Liu Y; Liang C; Wang W; Xing Y; Wu J; Hu D
Chem Biol Interact; 2023 Sep; 382():110543. PubMed ID: 37263557
[TBL] [Abstract][Full Text] [Related]
14. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
Wang Y; Mei X; Song W; Wang C; Qiu X
BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
17. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
18. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
[TBL] [Abstract][Full Text] [Related]
19. BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.
Wang M; He T; Meng D; Lv W; Ye J; Cheng L; Hu J
J Proteome Res; 2023 Dec; 22(12):3854-3865. PubMed ID: 37955350
[TBL] [Abstract][Full Text] [Related]
20. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
